MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells

Strahlentherapie und Onkologie

Volumn 189, Issue 8, 2013, Pages 675-683

  Wu, S Y ^a,b   Lin, K C ^a   Chiou, J F ^c,d   Jeng, S C ^d   Cheng, W H ^a   Chang, C L ^a   Lin, W C ^a   Wu, L L ^e   Lee, H L ^a   Chen, R J ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

miR 17 5p; OC3 cells; p21; Radiation; Radiation tolerance

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MICRORNA; MICRORNA17 5P; PROTEIN P21; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BETEL NUT; CANCER RADIOTHERAPY; CARCINOMA CELL; CELL CYCLE PROGRESSION; CELL SURVIVAL; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; DNA BINDING; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MASTICATION; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADMINISTRATION, ORAL; ARECA; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOUTH NEOPLASMS; RADIATION TOLERANCE; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 84881218712     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0347-9     Document Type: Article

References (23)

1. Lee CH, Ko AM, Warnakulasuriya S et al (2011) Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer 129:1741-1751
2. Wong P, Iwasaki M, Somervaille TC et al (2010) The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression. Cancer Res 70:3833-3842
3. He L, Thomson JM, Hemann MT et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828-833
4. Mu P, Han YC, Betel D et al (2009) Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev 23:2806-2811
5. Olive V, Bennett MJ, Walker JC et al (2009) miR-19 is a key oncogenic component of mir-17-92. Genes Dev 23:2839-2849
6. Glorian V, Maillot G, Polès S et al (2011) HuR-dependent loading of miRNA RISC to the mRNA encoding the Ras-related small GTPase RhoB controls its translation during UV-induced apoptosis. Cell Death Differ 18:1692-1701
7. Lin SC, Liu CJ, Chiu CP et al (2004) Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med 33:79-86
8. Mirzayans R, Andrais B, Scott A, Murray D (2012) New insights into p53 signaling and cancer cell response to DNA damage. J Biomed Biotechnol 2012:170325
9. Lossaint G, Besnard E, Fisher D et al (2011) Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Oncogene 30:4261-4274
10. Gomes CC, Gomez RS (2008) MicroRNA and oral cancer: future perspectives. Oral Oncol 44:910-914
11. Fontana L, Fiori ME, Albini S et al (2008) Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 3:e2236
12. Wang Z, Liu M, Zhu H et al (2010) Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level. Int J Oncol 37:1315-1321
13. Leibowitz BJ, Qiu W, Liu H et al (2011) Uncoupling p53 functions in radiation-induced intestinal damage via PUMA and p21. Mol Cancer Res 9:616-625
14. Yang D, Tan M, Wang G, Sun Y (2012) The p21-dependent radiosensitization of human breast cancer cells by MLN4924, an investigational inhibitor of NEDD8 activating enzyme. PLoS One 7:e34079
15. Li B, Shi XB, Nori D et al (2011) Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate 71:567-574
16. Schilling D, Bayer C, Emmerich K et al (2012) Basal HIF-1alpha expression levels are not predictive for radiosensitivity of human cancer cell lines. Strahlenther Onkol 188:353-358
17. Kuhnt T, Klockenbrink U, Knipping S et al (2011) Adjuvant low single dose cisplatin-based concurrent radiochemotherapy of oral cavity and oropharynx carcinoma: impact of extracapsular nodal spread on distant metastases. Strahlenther Onkol 187:292-299
18. Staab A, Fleischer M, Loeffler J et al (2011) Small interfering RNA targeting HIF-1alpha reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro. Strahlenther Onkol 187:252-259
19. Eder-Czembirek C, Erovic BM, Czembirek C et al (2010) Betulinic acid a radiosensitizer in head and neck squamous cell carcinoma cell lines. Strahlenther Onkol 186:143-148
20. Moergel M, Meurer P, Ingel K et al (2011) Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1): a meta-analysis. Strahlenther Onkol 187:337-343
21. Pignon JP, Maître A le, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4-14
22. Wang JT, Palme CE, Morgan GJ et al (2011) Predictors of outcome in patients with metastatic cutaneous head and neck squamous cell carcinoma involving cervical lymph nodes: improved survival with the addition of adjuvant radiotherapy. Head Neck 34:1524-1528
23. Kreppel M, Drebber U, Eich HT et al (2011) Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy. Strahlenther Onkol 187:555-560